Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation
Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation |
|
https://doi.org/10.18632/oncotarget.23723
Li Li,
Yi Li,
Jun Zhang,
Qiuji Wu,
Haijun Yu,
Zheng Li,
Conghua Xie,
Yunfeng Zhou,
and Yahua Zhong
|
| 26980-26989 |
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC) |
|
https://doi.org/10.18632/oncotarget.25454
Dominique Farge,
Francis Cajfinger,
Nicolas Falvo,
Toufek Berremili,
Francis Couturaud,
Okba Bensaoula,
Lionel Védrine,
Hocine Bensalha,
Isabelle Bonnet,
Denis Péré-Vergé,
Marie Coudurier,
Veronique Li,
Hanadi Rafii,
Ilham Benzidia,
Jean M. Connors,
and Matthieu Resche-Rigon
|
| 26990-26999 |
Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide |
|
https://doi.org/10.18632/oncotarget.25467
Jilian R. Melamed,
Joshua T. Morgan,
Stephen A. Ioele,
Jason P. Gleghorn,
Jennifer Sims-Mourtada,
and Emily S. Day
|
| 27000-27015 |
KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors |
|
https://doi.org/10.18632/oncotarget.25469
Yoshiyuki Suehara,
Keisuke Akaike,
Kenta Mukaihara,
Aiko Kurisaki-Arakawa,
Daisuke Kubota,
Taketo Okubo,
Hiroyuki Mitomi,
Keiko Mitani,
Michiko Takahashi,
Midori Toda-Ishii,
Youngji Kim,
Yu Tanabe,
Tatsuya Takagi,
Takuo Hayashi,
Kaoru Mogushi,
Kazuo Kaneko,
Takashi Yao,
and Tsuyoshi Saito
|
| 27016-27026 |
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases |
|
https://doi.org/10.18632/oncotarget.25471
Sven H. Loosen,
Frank Tacke,
Marcel Binnebosel,
Catherine Leyh,
Mihael Vucur,
Florian Heitkamp,
Wenzel Schoening,
Tom F. Ulmer,
Patrick H. Alizai,
Christian Trautwein,
Alexander Koch,
Thomas Longerich,
Christoph Roderburg,
Ulf P. Neumann,
and Tom Luedde
|
| 27027-27038 |
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.25472
Meriem Sarah Mekki,
Alexandra Mougel,
Audrey Vinchent,
Charlotte Paquet,
Marie-Christine Copin,
Catherine Leroy,
Zoulika Kherrouche,
Jean-Paul Bonte,
Oleg Melnyk,
Jérôme Vicogne,
and David Tulasne
|
| 27039-27058 |
LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice
LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice |
|
https://doi.org/10.18632/oncotarget.25473
Eloise Ferreira,
Monique J. Bignoux,
Tyrone C. Otgaar,
Nicolas Tagliatti,
Katarina Jovanovic,
Boitelo T. Letsolo,
and Stefan F.T. Weiss
|
| 27059-27073 |
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
|
https://doi.org/10.18632/oncotarget.25478
Teresa Morán,
Eudald Felip,
Joaquim Bosch-Barrera,
Itziar de Aguirre,
Jose Luis Ramirez,
Carles Mesia,
Enric Carcereny,
Diana Roa,
Elia Sais,
Yolanda García,
Remei Blanco,
Silvia Sanchez,
Claudia Rosa Villacorta,
Cristina Queralt,
Jose María Velarde,
and Rafael Rosell
|
| 27074-27086 |
Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines
Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines |
|
https://doi.org/10.18632/oncotarget.25484
Helin Feng,
Heather Tillman,
Gang Wu,
Andrew M. Davidoff,
and Jun Yang
|
| 27087-27091 |
Favorable prognostic role of tropomodulins in neuroblastoma
Favorable prognostic role of tropomodulins in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25491
Paola Bettinsoli,
Giulia Ferrari-Toninelli,
Sara Anna Bonini,
Michela Guarienti,
Davide Cangelosi,
Luigi Varesio,
and Maurizio Memo
|
| 27092-27103 |
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25497
Jonathan P. Evans,
Boleslaw K. Winiarski,
Paul A. Sutton,
Robert P. Jones,
Lorenzo Ressel,
Carrie A. Duckworth,
Mark D. Pritchard,
Zhi-Xiu Lin,
Vicky L. Fretwell,
Elizabeth M. Tweedle,
Eithne Costello,
Christopher E. Goldring,
Ian M. Copple,
Kevin B. Park,
Daniel H. Palmer,
and Neil R. Kitteringham
|
| 27104-27116 |
Reduced vasorin enhances angiotensin II signaling within the aging arterial wall
Reduced vasorin enhances angiotensin II signaling within the aging arterial wall |
|
https://doi.org/10.18632/oncotarget.25499
Gianfranco Pintus,
Roberta Giordo,
Yushi Wang,
Wanqu Zhu,
Soo Hyuk Kim,
Li Zhang,
Leng Ni,
Jing Zhang,
Richard Telljohann,
Kimberly R. McGraw,
Robert E. Monticone,
Chloe Ferris,
Lijuan Liu,
Mingyi Wang,
and Edward G. Lakatta
|
| 27117-27132 |
Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells
Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25500
Jan Baumann,
Mostafa Kokabee,
Jason Wong,
Rakshika Balasubramaniyam,
Yan Sun,
and Douglas S. Conklin
|
| 27133-27150 |
Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells
Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells |
|
https://doi.org/10.18632/oncotarget.25502
Aina Bernal,
Marc Moltó-Abad,
Daniel Domínguez,
and Laura Tusell
|
| 27151-27170 |
Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients
Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25506
Ali Abouelghar,
Reem Hasnah,
Ghina Taouk,
Mohamad Saad,
and Manale Karam
|
| 27171-27196 |
WNK1 kinase and its partners Akt, SGK1 and NBC-family Na+/HCO3– cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling
WNK1 kinase and its partners Akt, SGK1 and NBC-family Na+/HCO3– cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling |
|
https://doi.org/10.18632/oncotarget.25509
Wanyin Chen,
Leonel Nguekeu Zebaze,
Jihu Dong,
Laëtitia Chézeau,
Perrine Inquimbert,
Sylvain Hugel,
Songlin Niu,
Fréderic Bihel,
Emmanuel Boutant,
Eléonore Réal,
Pascal Villa,
Marie-Pierre Junier,
Hervé Chneiweiss,
Marcel Hibert,
Jacques Haiech,
Marie-Claude Kilhoffer,
and Maria Zeniou
|
| 27197-27219 |
Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance
Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance |
|
https://doi.org/10.18632/oncotarget.25513
Augustin Le Naour,
Renaud Mevel,
Benoit Thibault,
Elise Courtais,
Elodie Chantalat,
Jean Pierre Delord,
Bettina Couderc,
Julie Guillermet-Guibert,
and Alejandra Martinez
|
| 27220-27232 |
Construction and characterization of a new TRAIL soluble form, active at picomolar concentrations
Construction and characterization of a new TRAIL soluble form, active at picomolar concentrations |
|
https://doi.org/10.18632/oncotarget.25519
Matias Eliseo Melendez,
Renato José Silva-Oliveira,
Anna Luiza Silva Almeida Vicente,
Lidia Maria Rebolho Batista Arantes,
Ana Carolina de Carvalho,
Alberto Luis Epstein,
Rui Manuel Reis,
and André Lopes Carvalho
|
| 27233-27241 |
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer |
|
https://doi.org/10.18632/oncotarget.25531
Shinji Nakamichi,
Masahiro Seike,
Akihiko Miyanaga,
Mika Chiba,
Fenfei Zou,
Akiko Takahashi,
Arimi Ishikawa,
Shinobu Kunugi,
Rintaro Noro,
Kaoru Kubota,
and Akihiko Gemma
|
| 27242-27255 |
Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer
Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer |
|
https://doi.org/10.18632/oncotarget.25535
David Weber,
Laurence Amar,
Daniel Gödde,
and Christian Prinz
|
| 27256-27267 |
Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells
Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells |
|
https://doi.org/10.18632/oncotarget.25545
Alina D. Nikotina,
Lidia Koludarova,
Elena Y. Komarova,
Elena R. Mikhaylova,
Nikolay D. Aksenov,
Roman Suezov,
Viktor G. Kartzev,
Boris A. Margulis,
and Irina V. Guzhova
|
| 27268-27279 |
Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases
Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases |
|
https://doi.org/10.18632/oncotarget.25546
Anna Han,
Natalie Bennett,
Bettaieb Ahmed,
Jay Whelan,
and Dallas R. Donohoe
|
| 27280-27292 |
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25551
Stefanie Thiele,
Ariane Zimmer,
Andy Göbel,
Tilman D. Rachner,
Sandra Rother,
Susanne Fuessel,
Michael Froehner,
Manfred P. Wirth,
Michael H. Muders,
Gustavo B. Baretton,
Franz Jakob,
Martina Rauner,
and Lorenz C. Hofbauer
|
| 27293-27304 |
Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients
Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.25553
Egor V. Batorov,
Marina A. Tikhonova,
Natalia V. Pronkina,
Irina V. Kryuchkova,
Vera V. Sergeevicheva,
Svetlana A. Sizikova,
Galina Y. Ushakova,
Tatiana A. Aristova,
Dariya S. Batorova,
Elena V. Menyaeva,
Andrey V. Gilevich,
Ekaterina Y. Shevela,
Alexander A. Ostanin,
and Elena R. Chernykh
|
| 27305-27317 |
Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia
Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia |
|
https://doi.org/10.18632/oncotarget.25620
Aimin Qiao,
Kuansong Wang,
Yunsheng Yuan,
Yidi Guan,
Xingcong Ren,
Lanya Li,
Xisha Chen,
Feng Li,
Alex F. Chen,
Jianda Zhou,
Jin-Ming Yang,
and Yan Cheng
|
| 27318-27318 |
